To further assess the potential effects of AH23848 treatment on the responses of IFN-γ-producing CD4+ and CD8+ T cells in the CNS, we analyzed intracellular IFN-γ production by the T cells 8–9 days post-infection (Fig 6). The gene discussed is CD8A; the disease is infection.